It looks like your browser is not up to date.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Rite Aid Corp (RAD) COM NPV

Sell:$20.07 Buy:$20.08 Change: $0.42 (2.14%)
Market closed |  Prices as at close on 18 May 2021 | Switch to live prices |
Change: $0.42 (2.14%)
Market closed |  Prices as at close on 18 May 2021 | Switch to live prices |
Change: $0.42 (2.14%)
Market closed |  Prices as at close on 18 May 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Rite Aid Corporation is a healthcare company that operates retail drugstore chain. The Company is principally engaged in providing its service to customers and communities through various programs. Its business segments include Retail Pharmacy segment and Pharmacy Services segment. Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as front-end products, including health and beauty aids, personal care products and seasonal merchandise. Its Retail Pharmacy segment operates approximately 2,500 retail pharmacy locations across 19 states. Pharmacy Services segment provides a range of pharmacy benefit services through Elixir. Elixir also offers integrated mail-order and specialty pharmacy services through Elixir Pharmacy. The Pharmacy Services segment provides both transparent and traditional pharmacy benefit management (PBM) options through its Elixir PBM. The Company's clients include employers, insurance companies and unions.

Contact details

30 Hunter Ln
United States
+1 (717) 7612633

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$1.05 billion
Shares in issue:
55.10 million
Drug Retail
New York Stock Exchange
United States
US dollar

Key personnel

  • Bruce Bodaken
    Independent Chairman of the Board
  • Heyward Donigan
    President, Chief Executive Officer, Director
  • Matthew Schroeder
    Chief Financial Officer, Senior Vice President
  • James Peters
    Chief Operating Officer
  • Jocelyn Konrad
    Executive Vice President - Pharmacy and Retail Operations
  • Andre Persaud
    Executive Vice President - Retail
  • Justin Mennen
    Senior Vice President, Chief Information Officer
  • Erik Keptner
    Senior Vice President, Chief Marketing Officer
  • Trent Kruse
    Senior Vice President of Investor Relations, Treasury
  • Chris Bohrer
    Senior Vice President - Payor and Strategic Initiatives

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.